Women’s Health Market Size, Share & Trends Analysis By Application (Postmenopausal Osteoporosis, Infertility, Endometriosis, Contraceptives, Menopause, PCOS), By Region, And Segment Forecasts, 2019 - 2026

Published: Aug, 2019 | Pages: 130 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)

The global women’s health market size is expected to reach USD 54.6 billion by 2026, according to a new report by Grand View Research, Inc., expanding at a CAGR of 4.2% over the forecast period. Government and various private organizations are focused on women health across the globe, which is likely to drive the market in the coming years. Coverage provided to women is one of the key factors expected to drive the market in developed countries.

In the U.S., coverage plans provide preventive services for women without any copayment charges. This includes anemia screening on a routine basis, folic acid supplements for women who may become pregnant, hepatitis B screening, breast cancer screening, contraception, and many others. Healthy People 2020 was established by the Department of Health and Human Services to improve the health of all Americans in 10 years.

Initiatives by countries from the Asia Pacific region, such as India, China, Japan, Australia, and Singapore, are likely to boost the market over the forecast period. For instance, in September 2016, Ministry of Health, Australia, announced funding of AUD 5.6 million (around USD 3.8 million) until 2019 to Jean Hailes, a women’s health organization to help expand its education and outreach.

With aging and increasing incidence of obesity, the prevalence of OA is anticipated to grow. According to the United Nations, about 10% to 15% of all adults aged over 60 have some degree of OA, and the condition is more prevalent in women. According to the CDC, in 2013, back problems were more common in women (30.2%). According to the International Osteoporosis Foundation (IOF), the worldwide prevalence of osteoporosis among women was over 200.0 million in 1990, which is anticipated to reach 680.0 million in 2050.

Further Key Findings From the Study Suggest:

• Based on application, the women’s health market is segmented into postmenopausal osteoporosis, infertility, endometriosis, contraceptives, menopause, and Polycystic Ovary Syndrome (PCOS). Of these, postmenopausal osteoporosis held a majority of the market share in terms of revenue in 2018.

• Availability of a wide range of drugs for the treatment of postmenopausal osteoporosis is projected to boost the market. These include Fosamax, Actonel, Boniva, Reclast, Evista, and Prolia. In April 2017, the U.S. FDA approved a new drug, Tymlos, to treat postmenopausal osteoporosis. The approval was based on data of 18-month trial that demonstrated a substantial reduction in the risk of vertebral & nonvertebral fractures.

• North America held the largest market share in 2018 in terms of revenue pertaining to the technological advancements and presence of major market players in the region. Asia Pacific, on the other hand, is expected to showcase the fastest growth rate over the forecast period.

• Some of the key players in the market are Bayer AG; Allergan; Merck & Co., Inc.; Teva Pharmaceuticals; Pfizer; Agile Therapeutics; Amgen, Inc.; AstraZeneca, Bristol-Myers Squibb, Ferring B.V.

 Table of Contents

Chapter 1 Methodology and Scope
                    1.1 Market Segmentation & Scope
                        1.1.1 Application
                        1.1.2 Regional Scope
                        1.1.3 Estimates And Forecast Timeline
                    1.2 Research Methodology
                    1.3 Information procurement
                        1.3.1 Purchased Database
                        1.3.2 Gvr’s Internal Database
                        1.3.3 Secondary Sources
                        1.3.4 Primary Research
                    1.4 Information or Data Analysis
                        1.4.1 Data Analysis Models
                    1.5 Market Formulation & Validation
                    1.6 Model Details
                        1.6.1 Commodity Flow Analysis (Model 1)
                        1.6.2 Volume Price Analysis (Model 2)
                    1.7 List of Secondary Sources
                    1.8 Objectives
                        1.8.1 Objective - 1
                        1.8.2 Objective - 2

Chapter 2 Executive Summary
                    2.1 Market Outlook
                    2.2 Segment Outlook
                        2.2.1 Application
                        2.2.2 Region
                    2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope
                    3.1 Market Segmentation
                    3.2 Penetration & Growth Prospect Mapping
                        3.2.1 Penetration Analysis
                        3.2.2 Market Driver Analysis
                            3.2.2.1 Rising Incidence Of Target Disorders
                            3.2.2.2 Child Or Early Marriages
                            3.2.2.3 Initiatives By Government And Various Organizations
                        3.2.3 Market Restraint Analysis
                            3.2.3.1 Patent expiry of major drugs
                            3.2.3.2 Lawsuits related to contraceptives
                    3.3 Women’s Health Market: Business Environment Analysis Tools
                        3.3.1 Porter’s Five Forces Analysis
                        3.3.2 Pestel Analysis
                    3.4 Clinical Pipeline Analysis
                    3.5 Approval of Few Drugs in Recent Years

Chapter 4 Women’s Health Market: Drug Analysis
                    4.1 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Drug Segment
                        4.1.1 EVISTA
                            4.1.1.1 Evista market, 2015 - 2026 (USD Million)
                        4.1.2 XGEVA
                            4.1.2.1 Xgeva market, 2015 - 2026 (USD Million)
                        4.1.3 PROLIA
                            4.1.3.1 Prolia market, 2015 - 2026 (USD Million)
                        4.1.4 MIRENA
                            4.1.4.1 Mirena market, 2015 - 2026 (USD Million)
                        4.1.5 ZOMETA
                            4.1.5.1 Zometa market, 2015 - 2026 (USD Million)
                        4.1.6 RECLAST/ACLASTA
                            4.1.6.1 Reclast/Aclasta market, 2015 - 2026 (USD Million)
                        4.1.7 MINASTRIN 24FE
                            4.1.7.1 Minastrin 24FE market, 2015 - 2026 (USD Million)
                        4.1.8 NUVARING
                            4.1.8.1 NuvaRing market, 2015 - 2026 (USD Million)
                        4.1.9 FORTEO
                            4.1.9.1 Forteo market, 2015 - 2026 (USD Million)
                        4.1.10 PREMARIN
                            4.1.10.1 Premarin market, 2015 - 2026 (USD Million)
                        4.1.11 ACTONEL
                            4.1.11.1 Actonel market, 2015 - 2026 (USD Million)
                        4.1.12 ORTHO-TRI-CY LO 28
                            4.1.12.1 Ortho-Tri-Cy LO 28 market, 2015 - 2026 (USD Million)

Chapter 5 Women’s Health Market: Application Analysis
                    5.1 Women’s Health Application Market Share Analysis, 2018 & 2026
                    5.2 Women’s Health Application Market: Segment Dashboard:
                    5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
                        5.3.1 Postmenopausal Osteoporosis
                            5.3.1.1 Postmenopausal Osteoporosis Market, 2015 - 2026 (USD Million)
                        5.3.2 Hormonal Infertility
                            5.3.2.1 Hormonal Infertility Market, 2015 - 2026 (USD Million)
                        5.3.3 Endometriosis
                            5.3.3.1 Endometriosis Market, 2015 - 2026 (USD Million)
                        5.3.4 Contraceptives
                            5.3.4.1 Contraceptives Market, 2015 - 2026 (USD Million)
                        5.3.5 Menopause
                            5.3.5.1 Menopause Market, 2015 - 2026 (USD Million)
                        5.3.6 Polycystic Ovary Syndrome (Pcos)
                            5.3.6.1 Pcos Market, 2015 - 2026 (USD Million)

Chapter 6 Women’s Health Market: Regional Analysis
                    6.1 Women’s Health Regional Market Share Analysis, 2018 & 2026
                    6.2 Women’s Health Regional Market: Segment Dashboard
                    6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
                    6.4 Market Size, & Forecasts, and Trend Analysis, 2015 to 2026
                        6.4.1 North America
                            6.4.1.1 North America Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.1.1.1 U.S.
                                    6.4.1.1.1.1 Regulatory & Reimbursement Scenario
                                    6.4.1.1.1.2 U.S. Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.1.1.2 Canada
                                    6.4.1.1.2.1 Regulatory & Reimbursement Scenario
                                    6.4.1.1.2.2 Canada Women’s Health Market, 2015 - 2026 (USD Million)
                        6.4.2 Europe
                            6.4.2.1 Europe Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.2.1.1 Uk
                                    6.4.2.1.1.1 Regulatory & Reimbursement Scenario
                                    6.4.2.1.1.2 Uk Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.2.1.2 Germany
                                    6.4.2.1.2.1 Regulatory & Reimbursement Scenario
                                    6.4.2.1.2.2 Germany Women’s Health Market, 2015 - 2026 (USD Million)
                        6.4.3 Asia Pacific
                            6.4.3.1 Asia Pacific Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.3.1.1 Japan
                                    6.4.3.1.1.1 Regulatory & Reimbursement Scenario
                                    6.4.3.1.1.2 Japan Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.3.1.2 China
                                    6.4.3.1.2.1 Regulatory & Reimbursement Scenario
                                    6.4.3.1.2.2 China Women’s Health Market, 2015 - 2026 (USD Million)
                        6.4.4 Latin America
                            6.4.4.1 Latin America Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.4.1.1 Brazil
                                    6.4.4.1.1.1 Regulatory & Reimbursement Scenario
                                    6.4.4.1.1.2 Brazil Women’s Health Market, 2015 - 2026 (USD Million)
                                6.4.4.1.2 Mexico
                                    6.4.4.1.2.1 Regulatory & Reimbursement Scenario
                                    6.4.4.1.2.2 Mexico Women’s Health Market, 2015 - 2026 (USD Million)
                        6.4.5 Middle East And Africa (Mea)
                            6.4.5.1 MEA women’s health market, 2015 - 2026 (USD Million)
                                6.4.5.1.1 South Africa
                                    6.4.5.1.1.1 Regulatory & reimbursement scenario
                                    6.4.5.1.1.2 South Africa women’s health market, 2015 - 2026 (USD Million)

Chapter 7 Competitive Analysis
                    7.1 Recent Developments & Impact Analysis, By Key Market Participants
                    7.2 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
                    7.3 Company Profiles
                        7.3.1 ALLERGAN
                            7.3.1.1 Company overview
                            7.3.1.2 Financial performance
                            7.3.1.3 Product benchmarking
                            7.3.1.4 Strategic initiatives
                            7.3.1.5 Swot analysis
                        7.3.2 BAYER AG
                            7.3.2.1 Company overview
                            7.3.2.2 Financial performance
                            7.3.2.3 Product benchmarking
                            7.3.2.4 Strategic initiatives
                            7.3.2.5 Swot analysis
                        7.3.3 MERCK & CO., INC.
                            7.3.3.1 Company overview
                            7.3.3.2 Financial performance
                            7.3.3.3 Product benchmarking
                            7.3.3.4 Strategic initiatives
                            7.3.3.5 Swot analysis
                        7.3.4 PFIZER, INC.
                            7.3.4.1 Company overview
                            7.3.4.2 Financial performance
                            7.3.4.3 Product benchmarking
                            7.3.4.4 Strategic initiatives
                            7.3.4.5 Swot analysis
                        7.3.5 TEVA PHARMACEUTICAL INDUSTRIES LTD.
                            7.3.5.1 Company overview
                            7.3.5.2 Financial Performance
                            7.3.5.3 Product benchmarking
                            7.3.5.4 Strategic initiatives
                            7.3.5.5 Swot analysis
                        7.3.6 AGILE THERAPEUTICS
                            7.3.6.1 Company overview
                            7.3.6.2 Financial performance
                            7.3.6.3 Product benchmarking
                            7.3.6.4 Strategic initiatives
                        7.3.7 AMGEN, INC.
                            7.3.7.1 Company overview
                            7.3.7.2 Financial performance
                            7.3.7.3 Product benchmarking
                            7.3.7.4 Strategic initiatives
                            7.3.7.5 Swot analysis
                        7.3.8 APOTHECUS PHARMACEUTICAL CORP.
                            7.3.8.1 Company overview
                            7.3.8.2 Product benchmarking
                        7.3.9 ASTRAZENECA
                            7.3.9.1 Company overview
                            7.3.9.2 Financial performance
                            7.3.9.3 Product benchmarking
                            7.3.9.4 Strategic initiatives
                            7.3.9.5 Swot analysis
                        7.3.10 BLAIREX LABORATORIES, INC.
                            7.3.10.1 Company overview
                            7.3.10.2 Product benchmarking
                        7.3.11 BRISTOL-MYERS SQUIBB COMPANY
                            7.3.11.1 Company overview
                            7.3.11.2 Financial performance
                            7.3.11.3 Product benchmarking
                            7.3.11.4 Strategic initiatives
                            7.3.11.5 Swot analysis
                        7.3.12 FERRING B.V.
                            7.3.12.1 Company overview
                            7.3.12.2 Product benchmarking
                            7.3.12.3 Strategic initiatives

List of Tables

TABLE 1 List of Secondary Sources
TABLE 2 North America Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 3 North America Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 4 U.S. Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 5 Drug development process in Canada
TABLE 6 Canada Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 7 Europe Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 8 Europe Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 9 UK Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 10 Germany Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 11 Asia Pacific Women’s Health market, by country, 2015 - 2026 (USD Million)
TABLE 12 Asia Pacific Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 13 Japan Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 14 China Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 15 Latin America Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 16 Latin America Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 17 Brazil Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 18 Mexico Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 19 MEA Women’s Health Market, by Country, 2015 - 2026 (USD Million)
TABLE 20 MEA Women’s Health Market, by Application, 2015 - 2026 (USD Million)
TABLE 21 South Africa Women’s Health Market, by Application, 2015 - 2026 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain based sizing & forecasting
Fig. 6 QFD modelling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Women’s health market outlook, 2018
Fig. 9 Market trends & outlook
Fig. 10 Women’s health market segmentation
Fig. 11 Penetration & growth prospect mapping
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Market restraint relevance analysis (Current & future impact)
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTEL analysis
Fig. 16 Evista market, 2015 - 2026 (USD Million)
Fig. 17 Xgeva market, 2015 - 2026 (USD Million)
Fig. 18 Prolia market, 2015 - 2026 (USD Million)
Fig. 19 Mirena market, 2015 - 2026 (USD Million)
Fig. 20 Zometa market, 2015 - 2026 (USD Million)
Fig. 21 Reclast/Aclasta market, 2015 - 2026 (USD Million)
Fig. 22 Minastrin 24FE market, 2015 - 2026 (USD Million)
Fig. 23 NuvaRing market, 2015 - 2026 (USD Million)
Fig. 24 Forteo market, 2015 - 2026 (USD Million)
Fig. 25 Premarin market, 2015 - 2026 (USD Million)
Fig. 26 Actonel market, 2015 - 2026 (USD Million)
Fig. 27 Ortho-Tri-Cy LO 28 market, 2015 - 2026 (USD Million)
Fig. 28 Women’s health application market share analysis, 2018 & 2026
Fig. 29 Women’s health application market: Segment dashboard
Fig. 30 Postmenopausal osteoporosis market, 2015 - 2026 (USD Million)
Fig. 31 Hormonal infertility market, 2015 - 2026 (USD Million)
Fig. 32 Endometriosis market, 2015 - 2026 (USD Million)
Fig. 33 Contraceptives market, 2015 - 2026 (USD Million)
Fig. 34 Menopause market, 2015 - 2026 (USD Million)
Fig. 35 PCOS market, 2015 - 2026 (USD Million)
Fig. 36 Women’s health regional market share analysis, 2018 & 2026
Fig. 37 Women’s health regional market: Segment dashboard
Fig. 38 Regional market place: Key takeaways
Fig. 39 North America women’s health market, 2015 - 2026 (USD Million)
Fig. 40 U.S. women’s health market, 2015 - 2026 (USD Million)
Fig. 41 Canada women’s health market, 2015 - 2026 (USD Million)
Fig. 42 Europe women’s health market, 2015 - 2026 (USD Million)
Fig. 43 UK women’s health market, 2015 - 2026 (USD Million)
Fig. 44 Germany women’s health market, 2015 - 2026 (USD Million)
Fig. 45 Asia Pacific women’s health market, 2015 - 2026 (USD Million)
Fig. 46 Japan women’s health market, 2015 - 2026 (USD Million)
Fig. 47 China women’s health market, 2015 - 2026 (USD Million)
Fig. 48 Latin America women’s health market, 2015 - 2026 (USD Million)
Fig. 49 Brazil women’s health market, 2015 - 2026 (USD Million)
Fig. 50 Mexico women’s health market, 2015 - 2026 (USD Million)
Fig. 51 MEA women’s health market, 2015 - 2026 (USD Million)
Fig. 52 South Africa women’s health market, 2015 - 2026 (USD Million)
Fig. 53 Recent developments & impact analysis, by key market participants
Fig. 54 Strategy framework